Ben Lamm, cofounder and CEO of Colossal Biosciences, has become one of the most unconventional entrepreneurs of the AI-and-biotech era, turning de-extinction into a high-stakes commercial and scientific enterprise. A serial founder with multiple exits in software and artificial intelligence, he partnered with geneticist George Church to launch Colossal in 2021 and build it into one of the world’s most closely watched biotech startups. With its work spanning extinct species, conservation, and synthetic biology, Lamm has positioned himself at the intersection of frontier science, venture capital, and ambitious moonshot building.

Jon Winkelried, CEO of TPG, is a veteran Wall Street executive who helped lead Goldman Sachs before taking the helm at one of the world’s largest alternative asset managers. Since joining TPG in 2015 and becoming sole CEO in 2021, he has played a central role in scaling the firm’s reach across private equity, credit, real estate, and impact investing. Known for strategic discipline and institutional gravitas, Winkelried has become one of the most influential figures in modern private markets.

Josh Kushner, founder and managing partner of Thrive Capital, is one of the most influential venture investors of his generation, backing category-defining companies across fintech, healthcare, and consumer technology. Since launching Thrive in 2009, he has led early or transformative investments in firms such as Instagram, Stripe, Spotify, GitHub, and OpenAI, building Thrive into a multi-billion-dollar venture platform known for disciplined underwriting and long-horizon conviction. Kushner is also the cofounder of Oscar Health, a technology-driven insurer reshaping the U.S. healthcare landscape. With a rare combination of entrepreneurial experience, investment acumen, and strategic clarity, he has become a central force in shaping the next era of digital innovation.